
Please try another search
RayzeBio, Inc. develops radiopharmaceutical therapeutics for the treatment of cancer. The company was incorporated in 2020 and is based in San Diego, California. As of February 26, 2024, RayzeBio, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Name | Age | Since | Title |
---|---|---|---|
Sandra Ramos-Alves | - | 2024 | VP, Treasurer & Director |
Konstantina Katcheves | - | 2024 | Director |
Kimberly M. Jablonski | - | 2024 | VP, Secretary, Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review